Michael Brownell joined Gobiquity as CEO in 2012, with prior experience in a variety of leadership roles in ophthalmology and other industries. Gobiquity closed Series A financing with Interwest in July 2013.
Michael was part of the initial management team at IntraLase, and at the time of acquisition by AMO he was VP of Product Development. While at AMO he had expanding responsibilities across multiple technology groups.
Michael has an MS in physics and has held key roles at multiple start-ups, including Chief Technology Officer at Powerlase in the UK and VP of Product Development at GigaTera in Zurich.